"Sarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Descriptor ID |
D012509
|
| MeSH Number(s) |
C04.557.450.795
|
| Concept/Terms |
Sarcoma- Sarcoma
- Sarcomas
- Sarcoma, Soft Tissue
- Sarcomas, Soft Tissue
- Soft Tissue Sarcoma
- Soft Tissue Sarcomas
Sarcoma, Epithelioid- Sarcoma, Epithelioid
- Epithelioid Sarcoma
- Epithelioid Sarcomas
- Sarcomas, Epithelioid
Sarcoma, Spindle Cell- Sarcoma, Spindle Cell
- Sarcomas, Spindle Cell
- Spindle Cell Sarcoma
- Spindle Cell Sarcomas
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma".
This graph shows the total number of publications written about "Sarcoma" by people in this website by year, and whether "Sarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 2 | 1 | 3 |
| 1996 | 1 | 1 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 0 | 3 |
| 2000 | 5 | 0 | 5 |
| 2001 | 5 | 3 | 8 |
| 2002 | 2 | 3 | 5 |
| 2003 | 2 | 1 | 3 |
| 2004 | 5 | 1 | 6 |
| 2005 | 6 | 2 | 8 |
| 2006 | 6 | 1 | 7 |
| 2007 | 6 | 1 | 7 |
| 2008 | 1 | 2 | 3 |
| 2009 | 4 | 0 | 4 |
| 2010 | 2 | 4 | 6 |
| 2011 | 1 | 1 | 2 |
| 2012 | 5 | 0 | 5 |
| 2013 | 10 | 1 | 11 |
| 2014 | 2 | 1 | 3 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 0 | 2 |
| 2017 | 5 | 0 | 5 |
| 2018 | 5 | 0 | 5 |
| 2019 | 9 | 0 | 9 |
| 2020 | 11 | 0 | 11 |
| 2021 | 6 | 0 | 6 |
| 2022 | 6 | 0 | 6 |
| 2023 | 4 | 1 | 5 |
| 2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoma" by people in Profiles.
-
Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Jul; 8:e2400219.
-
The "Other" Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities. Adv Anat Pathol. 2024 Nov 01; 31(6):380-396.
-
Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative. J Surg Oncol. 2024 Jun; 129(7):1354-1363.
-
Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper. Gynecol Obstet Invest. 2024; 89(2):73-86.
-
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017. Cancer. 2024 03 01; 130(5):750-769.
-
Evaluating Tumor Hypoxia Radiosensitization Via Electron Paramagnetic Resonance Oxygen Imaging (EPROI). Mol Imaging Biol. 2024 Jun; 26(3):435-447.
-
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology. Am J Clin Pathol. 2023 09 01; 160(3):238-246.
-
Small biopsies in the head and neck: Bone and soft tissue. Semin Diagn Pathol. 2023 Sep; 40(5):353-370.
-
EBV-positive inflammatory FDC/FRC tumor: no longer pseudo or sarcoma! Blood. 2023 02 23; 141(8):961.
-
High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders. Cell Death Dis. 2022 11 26; 13(11):999.